Skip to content

SMARTLOAD GAB00 (REF GAB0000175)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · SMARTLOAD SENSAR 1PC CLEAR MONO 17.5D · Class 3

All models of SMARTLOAD (52)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 05050474621732), received between Jan 25, 2024 and Jun 27, 2025 — classified as 2 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 2 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Break1
  • Scratched Material1

Patient problems

  • Hyphema2
  • No Clinical Signs, Symptoms or Conditions2
  • Unspecified Eye / Vision Problem2
  • Corneal Edema1
  • Dry Eye(s)1
  • Hyperemia1
  • Inflammation1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 27, 2025Break; Break

    IT WAS REPORTED THAT THE PRELOADED MONOFOCAL INTRAOCULAR LENS (IOL) WAS DEFECTIVE. NO ADDITIONAL INFORMATION WAS RECEIVED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22352384 ↗
  • InjuryJul 15, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2022, THE PATIENT UNDERWENT CATARACT SURGERY IN THE RIGHT EYE (OD) AND THE MONOFOCAL INTRAOCULAR LENS (IOL) 17.5D WAS IMPLANTED. THE IOL WAS PREPARED WITH OPHTHALMIC VISCOSURGICAL DEVICE (OVD) FROM ANOTHER MANUFACTURER. DURING SURGERY AN HEMORRHAGE DUE TO CANALOPLASTY OCCURRED AND A DEEP SCLEROTOMY/SUTURE CANALOPLASTY SUPRACHOROIDAL DRAINAGE WAS PERFORMED AND AN OLOGEN IMPLANT (6 MM) WAS PLACED. THE PATIENT WAS HOSPITALIZED. ON (B)(6) 2022, THE PATIENT WAS EXAMINED AND PRESENTED AN INTRAOCULAR PRESSURE (IOP) OF 2 MMHG (-22 MMHG FROM THE BASELINE). THE UNCORRECTED DISTANCE VISUAL ACUITY (UCDVA) WAS HAND MOVEMENT. THE PATIENT PRESENTED WITH CORNEAL EDEMA, FOLDS IN DESCEMET'S AND HYPHEMA. THE PATIENT WAS ALSO DIAGNOSED WITH CONJUCTIVA CHEMOSIS AND STRESS FOLDS. ON (B)(6) 2022 THE PATIENT WAS EXAMINED AND PRESENTED AN IOP OF 5 MMHG (-19 MMHG FROM THE BASELINE). THE PATIENT ALSO PRESENTED WITH CONJUNCTIVAL HYPEREMIA/INJECTION AND HYPHEMA PERSISTED. THE PATIENT WAS DISCHARGED. THE HYPHEMA WAS REPORTED TO BE RESOLVED WITHOUT SEQUELAE ON (B)(6) 2022. THROUGH FOLLOW-UP, WE LEARNED THAT THE PATIENT IS FULLY RECOVERED. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: Corneal Edema; Hyphema; Unspecified Eye / Vision Problem

    MAUDE report 19746885 ↗
  • InjuryJul 15, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2022, THE PATIENT UNDERWENT CATARACT SURGERY IN THE LEFT EYE (OS) AND THE MONOFOCAL INTRAOCULAR LENS (IOL) 17.5D WAS IMPLANTED. THE IOL WAS PREPARED WITH OPHTHALMIC VISCOSURGICAL DEVICE (OVD) FROM ANOTHER MANUFACTURER. NO SURGICAL COMPLICATIONS OCCURRED. THE FOLLOWING WAS PERFORMED A SUTURE CANALOPASTY, A SUPRACHOROIDAL DRAINAGE, OLOGEN IMPLANT (6MM). THE PATIENT WAS HOSPITALIZED. ON FEBRUARY 8, 2022 THE PATIENT WAS EXAMINED AND PRESENTED AN INTRAOCULAR PRESSURE (IOP) OF 12 MMHG (-7 MMHG FROM THE BASELINE). THE UNCORRECTED DISTANCE VISUAL ACUITY (UCDVA) WAS HAND MOVEMENT. THE PATIENT ALSO PRESENTED CONJUCTIVAL HYPEREMIA/INJECTION AND DRY EYE/SUPERFICIAL PUNCTATE KERATOPATHY/PUNCTATE EPITHELIAL EROSION/TEAR FILM INSUFFICIENCY; AND CELLS IN THE ANTERIOR CHAMBER. THE PATIENT ALSO PRESENTED AN IRIS BASE TEAR. ON (B)(6) 2022, THE PATIENT WAS DISCHARGED. THE HYPHEMA RESOLVED WITHOUT SEQUELAE. THROUGH FOLLOW-UP, WE LEARNED THAT THE PATIENT IS FULLY RECOVERED. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: Dry Eye(s); Hyperemia; Hyphema; Inflammation; Unspecified Eye / Vision Problem

    MAUDE report 19746879 ↗
  • MalfunctionJan 25, 2024Scratched Material; Scratched Material

    IT WAS REPORTED THAT THE PRELOADED INTRAOCULAR LENS (IOL) WAS SCRATCHED BY THE SHOOTER DURING IMPLANTATION. A NEW LENS WITH THE SAME DIOPTER WAS IMPLANTED. NO ADDITIONAL INFORMATION WAS RECEIVED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18581724 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page